Abbott's Investigational Tendyne(TM) Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study

Promising results for Tendyne valve presented as late-breaking clinical trial at EuroPCR Early data showed high rates of successful implantation and reduction of mitral regurgitation symptoms in patients in global study Device will be further studied... Devices, Interventional, Cardiology Abbott, Tendyne, Transcatheter, Mitral Valve Replacement, mitral regurgitation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news